Skip to content

Evaluation of the Accu-Chek® Combo System by subjects treated with CSII (Continuous Subcutaneous Insulin Infusion).

Evaluation of the Accu-Chek® Combo System by subjects treated with CSII (Continuous Subcutaneous Insulin Infusion). - Combo study

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON33856
Enrollment
65
Registered
2008-11-30
Start date
2008-12-11
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes Diabetes Mellitus

Interventions

In this study the following assessments / evaluations should be done: - 4 time bloodcollection for HbA1c measurement. - collection of 2 urine samples. - subject should answer 6 questionnaires. - daily

Sponsors

Disetronic Medical System AG
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Subjects must be 18 years or older at the time of the screening visit • Subjects must have an HbA1c

Exclusion criteria

Exclusion criteria: • Subjects who used systemic oral or inhaled steroids for > 14 days within the last 3 months • Subjects on Chemotherapy or Radiation therapy (self-reported) • Subjects currently addicted to alcohol or substances of abuse as determined by the investigator • Subjects planning to relocate or travel extensively (for periods of more than 2 weeks during phase I of the study • Subjects with psychological issues which would impair ability to consent or participate (at the Physicians* discretion) • Subjects show have had severe hypoglycemia requiring 3rd party assistance within the last 4 weeks • Subjects who are either pregnant or lactating or are currently planning a pregnancy

Design outcomes

Primary

MeasureTime frame
End point data for this study will be obtained from the following sources: 1: From pump downloads: 2: From meter downloads: 3: From Diary 4 :From Questionnaires

Secondary

MeasureTime frame
Not Applicable.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)